Weiss Ratings Reaffirms "Hold (C)" Rating for Escalade (NASDAQ:ESCA)

Key Points

• Weiss Ratings has reiterated a "Hold (C)" rating for Escalade (NASDAQ: ESCA), indicating no change in the stock's investment stance as of Wednesday.
• Escalade's stock is currently valued at $11.86 and has seen a 2.3% decline recently, with a year low of $11.74 and a high of $16.99.
• The company reported $0.13 EPS for the last quarter, falling short of analysts' expectations of $0.23, alongside revenue of $54.33 million against a forecast of $60.03 million.

Escalade (NASDAQ:ESCA - Get Free Report)'s stock had its "hold (c)" rating reiterated by equities researchers at Weiss Ratings in a research note issued on Wednesday,Weiss Ratings reports.

Separately, Wall Street Zen lowered shares of Escalade from a "buy" rating to a "hold" rating in a research note on Sunday, August 10th. One investment analyst has rated the stock with a Hold rating, According to data from MarketBeat, Escalade currently has an average rating of "Hold".

Escalade Stock Down 2.3%

Shares of NASDAQ:ESCA opened at $11.86 on Wednesday. The company has a debt-to-equity ratio of 0.09, a current ratio of 4.15 and a quick ratio of 1.79. The firm has a market capitalization of $163.67 million, a PE ratio of 13.03 and a beta of 0.69. The firm's 50-day moving average is $12.52 and its two-hundred day moving average is $13.80. Escalade has a 1 year low of $11.74 and a 1 year high of $16.99.

Escalade (NASDAQ:ESCA - Get Free Report) last issued its quarterly earnings results on Friday, August 1st. The company reported $0.13 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.23 by ($0.10). The business had revenue of $54.33 million for the quarter, compared to analysts' expectations of $60.03 million. Escalade had a return on equity of 6.86% and a net margin of 5.30%. Analysts predict that Escalade will post 0.93 EPS for the current year.

Insider Transactions at Escalade

In related news, Director Richard Fenton Baalmann, Jr. sold 4,800 shares of the company's stock in a transaction that occurred on Monday, September 15th. The stock was sold at an average price of $12.29, for a total value of $58,992.00. Following the completion of the transaction, the director directly owned 110,394 shares of the company's stock, valued at $1,356,742.26. This represents a 4.17% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. 28.75% of the stock is owned by company insiders.

Institutional Investors Weigh In On Escalade

Large investors have recently modified their holdings of the company. Rehmann Capital Advisory Group acquired a new stake in shares of Escalade in the first quarter valued at approximately $4,731,000. Ritholtz Wealth Management acquired a new stake in shares of Escalade in the first quarter valued at approximately $305,000. Bank of America Corp DE boosted its holdings in shares of Escalade by 17.0% in the fourth quarter. Bank of America Corp DE now owns 17,269 shares of the company's stock valued at $247,000 after acquiring an additional 2,510 shares during the period. GAMMA Investing LLC boosted its holdings in shares of Escalade by 27,223.8% in the first quarter. GAMMA Investing LLC now owns 5,738 shares of the company's stock valued at $88,000 after acquiring an additional 5,717 shares during the period. Finally, Nuveen LLC acquired a new stake in shares of Escalade in the first quarter valued at approximately $224,000. 65.22% of the stock is owned by institutional investors and hedge funds.

About Escalade

Escalade, Incorporated, together with its subsidiaries, manufactures, distributes, imports, and sells sporting goods in North America, Europe, and internationally. The company provides various sporting goods brands in basketball goals, archery, indoor and outdoor game recreation, and fitness products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.